Search research articles
Contact Us
Filters
Showing results (21-30 of 417) with videos related to
Page
of 42
Sort By:
Journal of the National Cancer Institute
|
August 17, 1988
Can a clinical trial be the treatment of choice for patients with cancer?
R D Gelber, A Goldhirsch
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 25, 2014
Reply to: prediction of benefit from chemotherapy in ER-positive/HER2-negative breast cancer
A Goldhirsch, A S Coates
The New England Journal of Medicine
|
May 5, 1994
Understanding adjuvant chemotherapy for breast cancer
A Goldhirsch, R D Gelber
Annals of Internal Medicine
|
January 1, 1988
Meta-analysis in clinical research
R D Gelber, A Goldhirsch
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1989
Randomized perioperative therapy in operable breast cancer: the Ludwig Trial V
A Goldhirsch, R D Gelber
Cancer Treatment and Research
|
January 1, 1992
Models for weighing benefits and toxicities
R D Gelber, A Goldhirsch
Journal of the National Cancer Institute. Monographs
|
January 1, 1992
Reporting and interpreting adjuvant therapy clinical trials. International Breast Cancer Study Group (formerly Ludwig Group)
R D Gelber, A Goldhirsch
Chest
|
July 1, 1989
Clinical trials for clinicians
R D Gelber, A Goldhirsch
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 1991
Meta-analysis: the fashion of summing-up evidence. Part I. Rationale and conduct
R D Gelber, A Goldhirsch
Seminars in Oncology
|
August 1, 1996
Endocrine therapies of breast cancer
A Goldhirsch, R D Gelber
Page
of 42
Search research articles
Search
Showing results (21-30 of 417) with videos related to
Sort By:
Page
of 42
Journal of the National Cancer Institute
|
August 17, 1988
Can a clinical trial be the treatment of choice for patients with cancer?
R D Gelber, A Goldhirsch
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 25, 2014
Reply to: prediction of benefit from chemotherapy in ER-positive/HER2-negative breast cancer
A Goldhirsch, A S Coates
The New England Journal of Medicine
|
May 5, 1994
Understanding adjuvant chemotherapy for breast cancer
A Goldhirsch, R D Gelber
Annals of Internal Medicine
|
January 1, 1988
Meta-analysis in clinical research
R D Gelber, A Goldhirsch
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1989
Randomized perioperative therapy in operable breast cancer: the Ludwig Trial V
A Goldhirsch, R D Gelber
Cancer Treatment and Research
|
January 1, 1992
Models for weighing benefits and toxicities
R D Gelber, A Goldhirsch
Journal of the National Cancer Institute. Monographs
|
January 1, 1992
Reporting and interpreting adjuvant therapy clinical trials. International Breast Cancer Study Group (formerly Ludwig Group)
R D Gelber, A Goldhirsch
Chest
|
July 1, 1989
Clinical trials for clinicians
R D Gelber, A Goldhirsch
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 1991
Meta-analysis: the fashion of summing-up evidence. Part I. Rationale and conduct
R D Gelber, A Goldhirsch
Seminars in Oncology
|
August 1, 1996
Endocrine therapies of breast cancer
A Goldhirsch, R D Gelber
Page
of 42